Geode Capital Management’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,834
| Closed | -$57K | – | 4587 |
|
|
2025
Q1 | $57K | Sell |
12,834
-357
| -3% | -$1.53K | ﹤0.01% | 4174 |
|
|
2024
Q4 | $52.4K | Sell |
13,191
-628
| -5% | -$2.54K | ﹤0.01% | 4237 |
|
|
2024
Q3 | $56.5K | Buy |
13,819
+119
| +0.9% | +$437 | ﹤0.01% | 4239 |
|
|
2024
Q2 | $50.7K | Buy |
+13,700
| New | +$54.6K | ﹤0.01% | 4276 |
|
|
2023
Q4 | – | Sell |
-8,094
| Closed | -$46K | – | 4707 |
|
|
2023
Q3 | $46K | Buy |
8,094
+1,175
| +17% | +$7.63K | ﹤0.01% | 4437 |
|
|
2023
Q2 | $53.9K | Hold |
6,919
| – | – | ﹤0.01% | 4489 |
|
|
2023
Q1 | $80.8K | Hold |
6,919
| – | – | ﹤0.01% | 4407 |
|
|
2022
Q4 | $81K | Sell |
6,919
-14
| -0.2% | -$199 | ﹤0.01% | 4467 |
|
|
2022
Q3 | $154K | Buy |
6,933
+66
| +1% | +$1.81K | ﹤0.01% | 4352 |
|
|
2022
Q2 | $202K | Buy |
6,867
+129
| +2% | +$3.85K | ﹤0.01% | 4259 |
|
|
2022
Q1 | $224K | Buy |
6,738
+2,351
| +54% | +$83.6K | ﹤0.01% | 4323 |
|
|
2021
Q4 | $176K | Hold |
4,387
| – | – | ﹤0.01% | 4536 |
|
|
2021
Q3 | $355K | Buy |
+4,387
| New | +$393K | ﹤0.01% | 4185 |
|
|
2015
Q4 | – | Sell |
-11
| Closed | -$23K | – | 4156 |
|
|
2015
Q3 | $23K | Hold |
11
| – | – | ﹤0.01% | 4083 |
|
|
2015
Q2 | $24K | Hold |
11
| – | – | ﹤0.01% | 3928 |
|
|
2015
Q1 | $45K | Hold |
11
| – | – | ﹤0.01% | 3861 |
|
|
2014
Q4 | $52K | Buy |
+11
| New | +$48.2K | ﹤0.01% | 3870 |
|
Geode Capital Management's NURO Position: Q2 2025 in Review
Geode Capital Management sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 12,834 shares — an estimated $57K sold.
Geode Capital Management first reported a position in NURO in Q4 2014 and held it in 17 quarters. The position peaked at $355K in Q3 2021. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.
- Geode Capital Management reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Geode Capital Management sold 12,834 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $57K.
- Geode Capital Management first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2014 and held it in 17 quarters.
- Geode Capital Management's NeuroMetrix, Inc. Common Stock position peaked at $355K in Q3 2021.
- 0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.
Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.